Results 331 to 340 of about 784,305 (383)

Fat taste sensitivity in women with obesity: transcriptomic analysis of fungiform papillae before and after bariatric surgery

Obesity, EarlyView.
Abstract Objective Fat taste sensitivity has been implicated in long‐term weight loss after bariatric surgery. Unexpectedly, improvement of orosensory fat acuity was not systematic in operated patients. Methods Obesity‐induced alterations of gene expression in gustatory papillae having been recently reported, we have explored the fungiform ...
Arnaud Bernard, Corentin Richard, Loredana Radoi, Romain Boidot, Séverine Ledoux, Philippe Besnard   +5 more
wiley   +1 more source

Correction to: Lipid Dysregulation in Tangier Disease: A Case Series and Metabolic Characterization.

J Clin Endocrinol Metab
europepmc   +1 more source

Editorial: Adrenal insufficiency: diagnostic approaches, treatments, and outcomes, volume II. [PDF]

Front Endocrinol (Lausanne)
Pazderska A, Malchoff CD, Valassi E.
europepmc   +1 more source

Long‐acting PYY3−36 analogue with semaglutide for obesity: from preclinical assessment through randomized clinical studies

Obesity, EarlyView.
Abstract Objective The hormone peptide YY (PYY; cleaved into Y2‐selective form PYY3‐36) is an attractive candidate for use as a complementary pharmacotherapy for obesity along with glucagon‐like peptide‐1 (GLP‐1) receptor agonists. This series of studies investigated a novel long‐acting PYY3‐36 analogue (PYY1875) alone and as an add‐on to semaglutide ...
Birgitte S. Wulff, Adam Paul Chambers, Cynthia Karenina Osorto Contreras, Katrine Kirkeby, Anders Rasmussen Rinnov, Riia K. Sustarsic, Søren Østergaard, John E. Laabs, Patrick M. O'Neil   +8 more
wiley   +1 more source

Estimating diagnostic delay in patients with pituitary adenomas in Sweden: a cross-sectional study. [PDF]

BMJ Open
Forsgren M, Dahlgren C, Alkebro C, Burman P, Dahlqvist P, Höbye C, Lindgren M, Ragnarsson O, Wik H, Wärn M, Åkerman AK, Eden Engström B, Ekman B, Follin C.   +13 more
europepmc   +1 more source

The mLIFE randomized trial examining the impact of gamifying social support provision for weight loss

Obesity, EarlyView.
Adults with overweight or obesity (n = 243) were randomized to the mLIFE + points (points for social support activities) or mLIFE group (no points). mLIFE + points participants lost 5.3 ± 0.6 kg at 12 months (vs. 3.5 ± 0.7 kg mLIFE; p = 0.09). Among adherent participants (n = 127), mLIFE + points participants lost more weight (7.3 ± 0.8 kg) than mLIFE (
Gabrielle M. Turner‐McGrievy, Diana Carolina Delgado‐Díaz, Kelli E. DuBois, Halide Zeynep Aydin, Courtney M. Monroe, Yesil Kim, James Hardin, Sara Wilcox, Homayoun Valafar   +8 more
wiley   +1 more source

Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status

Obesity, EarlyView.
Abstract Objective The objective of this study was to characterize changes in body weight and glycated hemoglobin (in those with prediabetes at baseline) through 12 months by obesity pharmacotherapy discontinuation status. Methods This retrospective cohort study used electronic health record data from a large health system in Ohio and Florida to ...
Hamlet Gasoyan, W. Scott Butsch, Rebecca Schulte, Nicholas J. Casacchia, Phuc Le, Christopher B. Boyer, Marcio L. Griebeler, Bartolome Burguera, Michael B. Rothberg   +8 more
wiley   +1 more source

Corrigendum: Surgical treatment strategies for gastroesophageal reflux after laparoscopic sleeve gastrectomy. [PDF]

Front Endocrinol (Lausanne)
Liu G, Wang P, Ran S, Xue X, Meng H.
europepmc   +1 more source

Retraction Note: PIWIL2 restrains the progression of thyroid cancer via interaction with miR-146a-3p. [PDF]

BMC Endocr Disord
Lu X, Zhu Q, Du H, Gu M, Li X.
europepmc   +1 more source